NHLS Alerts


2016 Alerts Archive


  • Interim guidance for the management of Candida Auris infections in South African hospitals

    22 December 2016 Please click to access pdf : Interim guidance for the management of Candida auris infections in South African hospitals

    More

    22 December 2016
  • Guidelines for the treatment of malaria in South Africa 2016 - 2017

    13 December 2016 Please click to access pdf: 2016/ 2017 South African National Guidelines for the Treatment of Malaria  

    More

    13 December 2016
  • World AIDS day 2016 – It is in our hands to end HIV&TB

    30 November 2016 The Centre for HIV and STIs (CHIVSTI) and the Centre for Opportunistic, Tropical and Hospital Infections (COTHI) at the National Institute for Communicable Diseases (NICD) which play key roles in HIV surveillance, programmatic evaluations and research – are honoured and proud to commemorate the 2016 World AIDS Day along with the Government of South Africa, the South African National AIDS Council, the National Health Laboratory Service and the people of South...

    More

    30 November 2016
  • NICD vaccine information booklet

    14 November 2016 Click link to download booklet : Vaccine information booklet for parents&caregivers Vaccines are widely acknowledged to be the most successful medical advance ever. Vaccines continue to save hundreds of thousands of lives annually. In South Africa, newer vaccines have been introduced as they have been developed, allowing protection against Haemophilus influenza type b, Streptococcus pneumoniae, hepatitis B, human papillomavirus and rotavirus. These vaccines...

    More

    14 November 2016
  • Advancing Gene Therapy To Counter The Global Impact Of Infection With Hepatitis B Virus

    14 November 2016 In the world it is estimated that there are 240 million people chronically infected with the hepatitis B virus (HBV). Hepatitis B prevalence is highest in sub-Saharan Africa and East Asia, where between 5–10% of the adult population is chronically infected. Chronic infection with HBV remains a global public health problem, despite the availability of a vaccine. Innovative developments such as gene therapy present new opportunities to advance curative anti-HBV...

    More

    14 November 2016